移植臓器におけるC型肝炎の再発

DOI

書誌事項

タイトル別名
  • Hepatitis C recurrence after orthotopic liver transplantation

この論文をさがす

抄録

<p>Hepatitis C recurrence after orthotopic liver transplantation (OLT) has been accepted as a major problem after OLT. Recent progress in hepatitis C virus (HCV) treatment with the use of direct acting antivirals (DAA) has almost resolved this major issue, as 95-100% of non-OLT hepatitis C patients in Japan reach a sustained viral response (SVR). However, the SVR rate among post-OLT hepatitis C patients in the United States and Europe is reported to be 90% and 10% of these patients require an additional approach. As the pathogenesis of hepatitis C involves immunological responses, post OLT hepatitis C exhibits complex phenomena with immune regulating agents including prednisolone and calcineurin inhibitors and HLA-mismatch in the recipient immune system and the donor liver. The pathogenesis and the recent progress in post-OLT hepatitis C are described in this chapter.</p>

収録刊行物

  • 移植

    移植 51 (2-3), 092-099, 2016

    一般社団法人 日本移植学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ